Molecular network analysis using reverse phase protein microarrays for patient tailored therapy

Advances in Experimental Medicine and Biology

Volumn 610, Issue , 2008, Pages 177-186

  Speer, Runa ^a   Wulfkuhle, Julia ^b   Espina, Virginia ^b   Aurajo, Robyn ^b   Edmiston, Kirsten H ^c   Liotta, Lance A ^b   Petricoin, Emanuel F ^b  

^a UNIVERSITY HOSPITAL TÜBINGEN   (Germany)

^b GEORGE MASON UNIVERSITY   (United States)

^c INOVA FAIRFAX HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

IMATINIB; TRASTUZUMAB;

CANCER CELL; CANCER RESEARCH; CLINICAL RESEARCH; FUNCTIONAL PROTEOMICS; HUMAN; METASTASIS; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN MICROARRAY; REVIEW; BIOLOGICAL MODEL; DNA MICROARRAY; GENOME; METABOLISM; METHODOLOGY; NEOPLASM; ONCOLOGY; PROTEOMICS; SIGNAL TRANSDUCTION;

GENOME, HUMAN; HUMANS; MEDICAL ONCOLOGY; MODELS, BIOLOGICAL; NEOPLASMS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PROTEIN ARRAY ANALYSIS; PROTEOMICS; SIGNAL TRANSDUCTION;

EID: 47949131537     PISSN: 00652598     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-0-387-73898-7_13     Document Type: Review

References (24)

1. Aebersold, R., Goodlett, D. R. (2001) Mass spectrometry in proteomics. Chem Rev 101(2), 269-95.
2. Bobrow, M. N., Shaughnessy, K. J., and Litt, G. J. (1991) Catalyzed reporter deposition, a novel method of signal amplification. II. Application to membrane immunoassays. J Immunol Methods. 137(1), 103-12.
3. Brennan, D. J. et al. (2005) Application of DNA microarray technology in determining breast cancer prognosis and therapeutic response. Expert Opin Biol Ther 5, 1069-1083.
4. Chakravarti, D. N., Chakravarti, B., Moutsatsos, I. (2002) Informatic tools for proteome profiling. Biotechniques Suppl 4-10: 12-5.
5. Emmert-Buck, M. R., et al. (1996) Laser capture microdissection. Science 274, 998-1001 (1996).
6. Giltrane, J. M. & Rimm, D. L. (2005) Technology insight: identification of biomarkers with tissue microarray technology. Nature Clin Pract Oncol 1, 104-111.
7. Grubb, R. L., et al. (2003) Signal pathway profiling of prostate cancer using reverse phase protein microarrays. Proteomics 3, 2142-2146.
8. Haab, B. B., Dunham, M. J., and Brown, P. O. (2001) Protein microarrays for highly parallel detection and quantitation of specific proteins and antibodies in complex solutions. Genome Biol 2(2).
9. Humphery-Smith, I., Wischerhoff, E., and Hashimoto, R. (2002) Protein arrays for assessment of target selectivity. Drug Discovery World 4(1), 17-27.
10. Liotta, L. A., Espina, V, Mehta, A. I., Calvert, V, Rosenblatt, K., Geho, D., Munson, P. J., Young, L., Wulfkuhle, J., and Petricoin, E. F. (2003) Protein microarrays: Meeting analytical challenges for clinical applications. Cancer Cell 3(4), 317-25.
11. Macbeath, G. (2002) Protein microarrays and proteomics. Nat Genet. 32 Suppl (526-32).
12. Paweletz, C. P., Charboneau, L., Roth, M. J., Bichsel, V. E., Simone, N. L., Chen, T., Han, N., Gillespie, J. W., Emmert-Buck, M., Petricoin, E. F., and Liotta, L. A. (2001) Reverse phase proteomic microarrays which capture disease progression show activation of pro-survival pathways at the cancer invasion front. Oncogene. Apr 12;20(16), 1981-9.
13. Panisko, E. A., Conrads, T. P., Goshe, M. B., Veenstra, T. D. (2002) The postgenomic age: characterization of proteomes. Exp Hematol 30(2), 97-107.
14. Petricoin, E., Wulfkuhle, J., Espina, V, and Liotta, L. A. (2004) Clinical proteomics: revolutionizing disease detection and patient-tailoring therapy. J Proteome Res. 3(2), 209-17.
15. Petricoin III, E. F., et al. (2005) Mapping molecular networks using proteomics: a vision for patient-tailored combination therapy. J Clin Oncol 23, 3614-3621.
16. Segal, E., Friedman, N., Kaminski, N., Regev, A. & Koller, D. (2005) From signatures to models: understanding cancer using microarrays. Nat Genet 37 Suppl., S38-S45.
17. Shankavaram, U. T, Reinhold, W C., Nishizuka, S., Major, S., Morita, D., Chary, K. K., Reimers, M. A., Scherf, U., Kahn, A., Dolginow, D., Cossman, J., Kaldjian, E. P., Scudiero, D. A., Petricoin, E., Liotta, L., Lee, J. K., Weinstein, J. N. (2007) Transcript and protein expression profiles of the NCI-60 cancer cell panel: an integromic microarray study. Mol Cancer Ther. Mar 5.
18. Sheehan, K. M., et al. (2005) Use of reverse-phase protein microarrays and reference standard development for molecular network analysis of metastatic ovarian carcinoma. Mol Cell Proteomics 4, 346-355.
19. Sjoblom, T, Jones, S., Wood, L. D., Parsons, D. W, Lin, J., Barber, T. D., Mandelker, D., Leary, R. J., Ptak, J., Silliman, N., Szabo, S., Buckhaults, P., Farrell, C., Meeh, P., Markowitz, S. D., Willis, J., Dawson, D., Willson, J. K., Gazdar, A. F., Hartigan, J., Wu, L., Liu, C., Parmigiani, G., Park, B. H., Bachman, K. E., Papadopoulos, N., Vogelstein, B., Kinzler, K. W., Velculescu, V. E. (2006) The consensus coding sequences of human breast and colorectal cancers. Science 314(7975), 268-74.
20. Wilson, D. S. and Nock, S. (2003) Recent developments in protein microarray technology. Angew Chem Int Ed Engl 42(5), 494-500.
21. Wulfkuhle, J. D., et al. (2003) Signal pathway profiling of ovarian cancer from human tissue specimens using reverse-phase protein microarrays. Proteomics 3, 2085-2090.
22. Wulfkuhle, J. D., Edmiston, K. H., Liotta, L. A., Petricoin, E. F. (2006) Technology Insight: phar-macoproteomics for cancer-promises of patient-tailored medicine using protein microarrays. Nat Clin Pract Oncol. May;3(5), 256-68.
23. Zha, H., et al. (2004) Similarities of pro-survival signals in Bcl-2-positive and Bcl-2-negative fol-licular lymhomas identified by reverse phase protein microarray. Lab Invest 84, 235-244.
24. Zhu, H. and Snyder, M. (2003) Protein chip technology. Curr Opin Chem Biol 7(1), 55-63.